Equity ResearchJune 26, 2025
$CW

Curtiss-Wright: Overvalued Amid Mean Reversion Risks

We initiate on CW at Sell, $373 PT. Curtiss-Wright Corporation (CW) specializes as a critical hardware & software engineering partner for defense, aer

5 min read
1,000 words
Rating
N/A
Price Target
N/A
Research Team
Moretus Research

We initiate on CW at Sell, $373 PT. Curtiss-Wright Corporation (CW) specializes as a critical hardware & software engineering partner for defense, aerospace, industrial, and nuclear power end- markets across the globe. While mgmt credibility on margin expansion & scale of record $3.6bn backlog inject heft into the NT growth story, we see the magnitude of dislocation in multiples as pointing to an imminent reckoning. CW trades at 24x NTM EV/EBITDA, with our above-consensus EBITDA estimates embedding through-by-FY26E op. leverage & superior mix in Defense Electronics. However, this premium to the historical median appears increasingly out of step with a macro regime increasingly defined by “higher-for-longer real rates” and continued liquidity withdrawal in a manufacturing cycle at best limping ALONG (ISM confirms contraction into mid-2025). Investors appear to be underwriting a perpetual geopolitical risk premium, despite the traditional dichotomy of multi-year topline visibility & momentary policy tailwinds versus unrelenting multiple mean reversion. Even if defense & nuclear outperform, segments exposed to industrial malaise & tariff drag range bound further revisions, with private-market and peer valuations several turns below here. While we acknowledge any upside surprise on defense appropriations or nuclear wins could puncture the thesis, the balance of valuation skew is overwhelmingly negative; downside compression vs upside catalysts for a stock priced for perfection sailing into headwinds. At these levels, risk far outweighs the reward regardless of business-level execution.

Markets are Challenged.

We view Curtiss-Wright’s current valuation premium as disconnected from underlying mean reversion risk and unsustainable at current levels. Shares recently traded at 22–24x forward P/E, a notable

Full Research Access Required

This research report contains proprietary analysis, financial models, and actionable insights. Access the complete report including detailed valuation methodology, risk assessment, and sector comparisons.

Financial Models
DCF & comps analysis
Risk Assessment
Scenario analysis
Sector Analysis
Peer comparison

Institutional clients: Contact your Moretus representative for immediate access. This research is for professional and institutional investors only.

Key Metrics

Market CapN/A
P/E RatioN/A
Dividend YieldN/A
NAV/ShareN/A

Important Disclosures: This research report is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results. Please see appendix for full disclosures and analyst certifications.

Related Research

View All Research →
Equity Research

Loading...

Research report details will appear here

Equity Research

Loading...

Research report details will appear here

Equity Research

Loading...

Research report details will appear here

© 2025 Moretus Advisors LLC. All rights reserved. This material is proprietary and may not be reproduced, transferred, or distributed in any form without prior written permission from Moretus.

This research report is prepared for institutional clients and qualified investors. It is not intended for retail investors. Please consult your financial advisor before making investment decisions.